Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 113-120

  Akagawa, Shin ^a   Ohuchida, Kenoki ^a   Torata, Nobuhiro ^a   Hattori, Masami ^a   Eguchi, Daiki ^a   Fujiwara, Kenji ^a   Kozono, Shingo ^a   Cui, Lin ^a   Ikenaga, Naoki ^a   Ohtsuka, Takao ^a   Aishima, Shinichi ^a   Mizumoto, Kazuhiro ^a,b   Oda, Yoshinao ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cancer stromal interaction; Myofibroblast; Pancreatic cancer; Peritoneal dissemination

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL INTERACTION; CELL INVASION; CELL ISOLATION; CELL MIGRATION; DISSEMINATED CANCER; HUMAN; HUMAN CELL; HUMAN PERITONEAL MYOFIBROBLAST; IN VITRO STUDY; LYMPH NODE METASTASIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PANCREAS CANCER; PANCREAS METASTASIS; PANCREATIC CANCER CELL LINE; PERITONEAL CAVITY; PRIMARY CULTURE; PRIORITY JOURNAL; STROMA CELL; TUMOR GROWTH; TUMOR INVASION; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; EXPERIMENTAL NEOPLASM; METABOLISM; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PERITONEUM; PERITONEUM TUMOR; SECONDARY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; HUMANS; MICE; MICE, NUDE; MYOFIBROBLASTS; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PERITONEUM;

EID: 84902581025     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2391     Document Type: Article

References (33)

1. Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet 378: 607-620, 2011.
2. Sener SF, Fremgen A, Menck HR and Winchester DP: Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189: 1-7, 1999.
3. Chu DZ, Lang NP, Thompson C, Osteen PK and Westbrook KC: Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63: 364-367, 1989.
4. Sadeghi B, Arvieux C, Glehen O, et al: Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88: 358-363, 2000.
5. Armstrong T, Packham G, Murphy LB, et al: Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10: 7427-7437, 2004.
6. Mahadevan D and Von Hoff DD: Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6: 1186-1197, 2007.
7. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N and Tuveson DA: The pancreas cancer microenvironment. Clin Cancer Res 18: 4266-4276, 2012.
8. Hwang RF, Moore T, Arumugam T, et al: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926, 2008.
9. Apte MV, Park S, Phillips PA, et al: Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 29: 179-187, 2004.
10. Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2009.
11. Strell C, Rundqvist H and Ostman A: Fibroblasts - a key host cell type in tumor initiation, progression, and metastasis. Ups J Med Sci 117: 187-195, 2012.
12. Fujita H, Ohuchida K, Mizumoto K, et al: Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci 100: 2309-2317, 2009.
13. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as 'soil' for peritoneal dissemination. Cancer 77: 1668-1675, 1996.
14. Cai J, Tang H, Xu L, et al: Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis 33: 20-29, 2012.
15. Peron JM, Bureau C, Gourdy P, et al: Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity. Gut 56: 107-114, 2007.
16. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413, 2003.
17. Tsukada T, Fushida S, Harada S, et al: The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int J Oncol 41: 476-482, 2012.
18. Epperly MW, Guo H, Gretton JE and Greenberger JS: Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29: 213-224, 2003.
19. Xu Z, Vonlaufen A, Phillips PA, et al: Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 177: 2585-2596, 2010.
20. Krist LF, Kerremans M, Broekhuis-Fluitsma DM, Eestermans IL, Meyer S and Beelen RH: Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity. Cancer Immunol Immunother 47: 205-212, 1998.
21. Mochizuki Y, Nakanishi H, Kodera Y, et al : TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 21: 39-47, 2004.
22. Sorensen EW, Gerber SA, Sedlacek AL, Rybalko VY, Chan WM and Lord EM: Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res 45: 185-194, 2009.
23. Tsujimoto H, Takhashi T, Hagiwara A, et al: Site-specific implantation in the milky spots of malignant cells in peritoneal dissemination: immunohistochemical observation in mice inoculated intraperitoneally with bromodeoxyuridine-labelled cells. Br J Cancer 71: 468-472, 1995.
24. Sugarbaker PH: Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol 95: 93-96, 2007.
25. Yashiro M, Chung YS, Inoue T, et al: Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 67: 289-293, 1996.
26. Bachem MG, Schneider E, Gross H, et al : Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421-432, 1998.
27. Bachem MG, Schunemann M, Ramadani M, et al: Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128: 907-921, 2005.
28. Jorres A, Ludat K, Lang J, et al: Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 7: 2192-2201, 1996.
29. Ohuchida K, Mizumoto K, Murakami M, et al: Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222, 2004.
30. + pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 139: 1041-1051, 2010.
31. Sato N, Maehara N, Mizumoto K, et al: Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer 91: 496-504, 2001.
32. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 14: 43-54, 1996.
33. Lv ZD, Na D, Ma XY, Zhao C, Zhao WJ and Xu HM: Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-β1 in vitro. Int J Mol Med 27: 187-193, 2011.